Julio Rosenstock
University College London Hospitals NHS Foundation Trust
2 papers in the Anchorcite directory, published between 2016 and 2021, cited 12,994 times in total.
ORCID profileResearch topics
- Diabetes Treatment and Management · 2 papers
- Diabetes, Cardiovascular Risks, and Lipoproteins · 1 paper
- Heart Failure Treatment and Management · 1 paper
- Pharmacology and Obesity Treatment · 1 paper
- Regulation of Appetite and Obesity · 1 paper
Frequent co-authors
- Ildiko Lingvay · 2 papers
- Steven P. Marso · 1 paper
- Stephen Charles Bain · 1 paper
- Agostino Consoli · 1 paper
- Freddy Goldberg Eliaschewitz · 1 paper
- Esteban Jódar · 1 paper
- Lawrence A. Leiter · 1 paper
- Jochen Seufert · 1 paper
Papers
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine · 2016 · 7,190 citations
BACKGROUND: Establishing cardiovascular safety of new therapies for type 2 diabetes is important. Safety data are available for the subcutaneous form of the glucagon-like peptide-1 receptor agonist semaglutide but are needed for oral semaglutide. METHODS: We assessed cardiovascular outcomes of…
- Once-Weekly Semaglutide in Adults with Overweight or ObesityNew England Journal of Medicine · 2021 · 5,804 citations
BACKGROUND: Obesity is a global health challenge with few pharmacologic options. Whether adults with obesity can achieve weight loss with once-weekly semaglutide at a dose of 2.4 mg as an adjunct to lifestyle intervention has not been confirmed. METHODS: In…
Metadata from OpenAlex (CC0).